{"product_id":"retatrutide","title":"Retatrutide","description":"\u003c!-- =========================================================\n  RETATRUTIDE — DISSOLV LABS\n  Shopify product description — paste into the Code View\n  of the product description field.\n========================================================= --\u003e\n\n\u003ch2\u003eRetatrutide — Research Peptide\u003c\/h2\u003e\n\u003cp\u003eRetatrutide is a synthetic investigational peptide referenced in the scientific literature as a single-molecule triple agonist at the \u003cstrong\u003eGLP-1\u003c\/strong\u003e, \u003cstrong\u003eGIP\u003c\/strong\u003e, and \u003cstrong\u003eglucagon\u003c\/strong\u003e receptor systems. DISSOLV LABS supplies Retatrutide as a high-purity analytical reference compound for qualified laboratory research professionals.\u003c\/p\u003e\n\n\u003cp\u003e\n  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% (HPLC-MS verified)\u003cbr\u003e\n  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilized powder, sealed amber vial\u003cbr\u003e\n  \u003cstrong\u003eDesignation:\u003c\/strong\u003e Research use only — not intended for human or veterinary use\n\u003c\/p\u003e\n\n\u003ch2\u003eCompound Overview\u003c\/h2\u003e\n\u003cp\u003eRetatrutide is classified within the multi-receptor incretin research peptide family. It is engineered as a unimolecular agonist that concurrently engages three structurally related receptor systems: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon.\u003c\/p\u003e\n\n\u003cp\u003eWithin peer-reviewed publications, Retatrutide is frequently positioned alongside Tirzepatide (a dual GLP-1\/GIP agonist) and Semaglutide (a GLP-1 agonist), and is studied as an extension of the broader incretin-class research lineage. It is among the most extensively profiled investigational peptides in current metabolic and endocrine research literature.\u003c\/p\u003e\n\n\u003ch2\u003eResearch Context\u003c\/h2\u003e\n\u003cp\u003eRetatrutide has been investigated in published preclinical and clinical research and is commonly referenced in laboratory work involving:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eComparative incretin receptor pharmacology\u003c\/li\u003e\n  \u003cli\u003eUnimolecular multi-agonist peptide structure–activity research\u003c\/li\u003e\n  \u003cli\u003eEnergy substrate signaling pathway models\u003c\/li\u003e\n  \u003cli\u003eGlucose homeostasis and metabolic signaling research\u003c\/li\u003e\n  \u003cli\u003eComparative peptide pharmacokinetics and stability profiling\u003c\/li\u003e\n  \u003cli\u003eReceptor binding affinity and selectivity studies\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eScientific Classification\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCompound name\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRetatrutide\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMolecular class\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSynthetic peptide\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFunctional category\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUnimolecular triple agonist (GLP-1 \/ GIP \/ glucagon)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePeptide family\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eIncretin-class multi-receptor agonist research peptides\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eResearch domains\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eIncretin biology, metabolic signaling, peptide pharmacology, receptor agonism\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAdjacent compounds\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eTirzepatide, Semaglutide, Cagrilintide, Cagrisema, AOD9604, HGH Fragment 176-191\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eAnalytical \u0026amp; Quality Standards\u003c\/h2\u003e\n\u003cp\u003eEvery Retatrutide lot supplied by DISSOLV LABS undergoes a structured analytical workflow designed to confirm identity, purity, and batch consistency before release.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePurity verification\u003c\/strong\u003e by reversed-phase high-performance liquid chromatography (RP-HPLC)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity confirmation\u003c\/strong\u003e by mass spectrometry (HPLC-MS)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResidual solvent and moisture screening\u003c\/strong\u003e to documented thresholds\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBatch-to-batch consistency\u003c\/strong\u003e recorded on a per-lot Certificate of Analysis (COA)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThird-party verification\u003c\/strong\u003e available upon institutional request\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSterile lyophilization\u003c\/strong\u003e under inert conditions to preserve peptide integrity\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eTechnical Specifications\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eLyophilized white powder\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAppearance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUniform, free-flowing solid\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePackaging\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSealed amber glass vial, crimped seal\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCatalog identifier\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDSL-RETA-001\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePurity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e≥99% (HPLC-MS verified)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRecommended storage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e−20 °C, protected from light and moisture\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eReconstitution\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSterile or bacteriostatic solvent (laboratory protocol only)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStability\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStable under recommended storage conditions; refer to lot COA\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eHandling\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRestricted to qualified research personnel\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat is Retatrutide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eRetatrutide is a synthetic investigational research peptide referenced in scientific literature as a unimolecular triple agonist at the GLP-1, GIP, and glucagon receptors. It is supplied by DISSOLV LABS as an analytical reference compound for laboratory research use only.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat category does Retatrutide belong to?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eRetatrutide is classified within the multi-agonist incretin research peptide family. It is studied alongside compounds such as Tirzepatide (dual GLP-1\/GIP agonist) and Semaglutide (GLP-1 agonist), and represents an extension of the unimolecular multi-receptor peptide research lineage.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat purity standard does DISSOLV LABS supply?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eDISSOLV LABS supplies Retatrutide at \u003cstrong\u003e≥99% purity\u003c\/strong\u003e, verified by reversed-phase HPLC and confirmed by mass spectrometry (HPLC-MS). Each lot is accompanied by a Certificate of Analysis.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat analytical testing is performed on each lot?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eEach Retatrutide lot is subjected to RP-HPLC purity analysis, HPLC-MS identity confirmation, residual solvent and moisture screening, and batch-consistency documentation. Third-party analytical verification is available upon institutional request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow should Retatrutide be stored?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eRecommended storage is \u003cstrong\u003e−20 °C\u003c\/strong\u003e, protected from light and moisture, in the original sealed vial. Refer to the lot-specific Certificate of Analysis for stability data.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow is Retatrutide reconstituted for laboratory work?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eRetatrutide is typically reconstituted with sterile or bacteriostatic solvent in accordance with the receiving laboratory's internal protocols. Reconstitution methodology is the responsibility of the qualified research professional.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs Retatrutide research use only?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. Retatrutide supplied by DISSOLV LABS is \u003cstrong\u003estrictly for laboratory research use only\u003c\/strong\u003e. It is not intended for human or veterinary use, and is not intended to diagnose, treat, cure, or prevent any disease.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat compounds are related to Retatrutide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eRetatrutide is commonly referenced alongside Tirzepatide, Semaglutide, Cagrilintide, Cagrisema, AOD9604, and HGH Fragment 176-191 — all of which are studied within metabolic and endocrine research domains.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow does Retatrutide differ from Tirzepatide and Semaglutide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eIn published research literature, Semaglutide is described as a single-receptor (GLP-1) agonist, Tirzepatide as a dual GLP-1\/GIP agonist, and Retatrutide as a unimolecular triple agonist engaging GLP-1, GIP, and glucagon receptors. Each compound occupies a distinct position within the incretin-class research peptide hierarchy.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs a Certificate of Analysis (COA) available?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. Every lot is shipped with a lot-specific Certificate of Analysis documenting purity, identity, and analytical methodology. COAs are available to verified research accounts on request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWho should handle Retatrutide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eRetatrutide is intended exclusively for handling by qualified laboratory research professionals operating within appropriate research facilities. It is not for sale to or use by the general public.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003ch2\u003eRelated Research Compounds\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTirzepatide\u003c\/strong\u003e — dual GLP-1 \/ GIP receptor agonist research peptide\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSemaglutide\u003c\/strong\u003e — GLP-1 receptor agonist research peptide\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCagrilintide\u003c\/strong\u003e — long-acting amylin analog research peptide\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCagrisema\u003c\/strong\u003e — combination research compound pairing Cagrilintide with Semaglutide\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAOD9604\u003c\/strong\u003e — modified hGH fragment research peptide (amino acids 177–191 with tyrosine modification)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHGH Fragment 176-191\u003c\/strong\u003e — C-terminal human growth hormone fragment research peptide\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCompliance\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only.\u003c\/strong\u003e This product is not intended for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Sale and distribution are restricted to qualified laboratory research professionals operating within appropriate research environments. The purchaser assumes full responsibility for safe handling, storage, and disposal in accordance with applicable institutional, local, and federal guidelines.\u003c\/p\u003e","brand":"Dissolv Labs","offers":[{"title":"10MG","offer_id":52101636817176,"sku":null,"price":37.0,"currency_code":"USD","in_stock":true},{"title":"20MG","offer_id":52101636849944,"sku":null,"price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0987\/0861\/9544\/files\/Retatrutide20mg.png?v=1779584871","url":"https:\/\/dissolv.com\/products\/retatrutide","provider":"Dissolv Labs","version":"1.0","type":"link"}